Canada markets closed

GlaxoSmithKline Pharmaceuticals Limited (GLAXO.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
2,619.30+25.00 (+0.96%)
At close: 03:30PM IST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Total Revenue
33,113,630
32,517,230
32,780,292
29,256,017
32,243,807
Cost of Revenue
13,860,430
13,587,230
14,496,539
13,388,156
13,975,445
Gross Profit
19,253,200
18,930,000
18,283,753
15,867,861
18,268,362
Operating Expenses
Selling General and Administrative
-
1,954,447
2,256,951
1,241,080
2,200,646
Total Operating Expenses
11,630,036
11,445,736
11,295,410
10,323,886
13,475,119
Operating Income or Loss
7,623,164
7,484,264
6,988,343
5,543,975
4,793,243
Interest Expense
16,822
18,122
19,961
35,314
57,225
Income Before Tax
7,355,400
8,364,000
7,790,481
4,539,905
3,057,531
Income Tax Expense
2,066,278
2,287,578
3,982,792
1,667,216
2,125,485
Income from Continuing Operations
5,289,122
6,076,422
3,807,689
2,872,689
932,046
Net Income
5,289,068
6,106,868
16,947,193
3,581,473
932,046
Net Income available to common shareholders
5,289,068
6,106,868
16,947,193
3,581,473
932,046
Basic EPS
38.24
36.05
100.04
21.14
5.50
Diluted EPS
38.24
36.05
100.04
21.14
5.50
Basic Average Shares
169,397
169,406
169,406
169,406
169,406
Diluted Average Shares
169,397
169,406
169,406
169,406
169,406